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a b s t r a c t
Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder, which causes
progressive muscle weakness and in severe cases respiratory failure and death. Although
the majority of the SMA cases are autosomal recessive, there is an autosomal dominant
variant of SMA that primarily affects the lower extremities, known as 'spinal muscular
atrophy – lower extremity, dominant' (SMALED). Mutations in the Dynein Cytoplasmic 1
Heavy Chain 1 (DYNC1H1) gene were the ﬁrst to be associated with SMALED. Here we report a
family with SMALED caused by a pathogenic heterozygous missense c.1809 A > T, p.
glu603Asp mutation in DYNC1H1. The main clinical features were congenital hip displace-
ment, talipes, delayed motor development, wasting and weakness in lower limbs with
relative sparing of upper extremities and very slow disease progression.
SMALED is extremely rare and only a handful of families have been reported. Over the
years other phenotypes including Charcot Marie Tooth type 2 and hereditary mental
retardation with cortical neural migration defects have also been reported to be caused
by DYNC1H1 mutations.
This report aims to increase our awareness of SMALED and various other phenotypes
associated with mutations in this gene.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Spinal muscular atrophy (SMA), a hereditary neuromuscular
disorder, is characterised by degeneration and loss of motor
neurons in the anterior horn of the spinal cord resulting in
progressive muscle weakness and, in severe cases respiratory
failure and death [1]. The majority of the SMA cases are
autosomal recessive and caused by homozygous deletion or
mutation of the SMN1 gene. However, there is an autosomal
dominant variant of SMA that affects primarily the lower
extremities, known as spinal muscular atrophy – lower
extremity, dominant (SMALED) [2].
Mutations in several genes have been associated with
SMALED, including Dynein Cytoplasmic 1 Heavy Chain 1
(DYNC1H1), protein bicaudal D homolog 2 (BICD2) and
transient receptor potential cation channel subfamily V
member 4 (TRPV4) [3–5]. Here we describe a family with
SMALED caused by a pathogenic missense mutation in
DYNC1H1. Mutations in this gene were the ﬁrst to be identiﬁed
as a cause of SMALED [3]. This gene encodes the force
generating subunit of the cytoplasmic dynein motor complex,
which participates in a wide variety of cellular functions, such
as shuttling of cellular constituents towards the minus ends
of the microtubules and numerous aspect of mitosis. These
functions make the dynein motor complex a critical player in
neurogenesis and migration [6].
2. Case description
The proband (Fig. 1A, III 2) presented to our neurology clinic
with a waddling gait and lower limb weakness since
childhood. He was born breech at 37 weeks and had bilateral
congenital hip dislocation as well as talipes equinovarus
requiring multiple surgeries in his childhood. He managed to
walk unaided at the age of 18 months. He often stumbled or
tripped due to his lower limb weakness and could only walk
short distances. Examination revealed an excessive lumbar
lordosis, and bilateral marked quadriceps wasting, pes cavus,
tight-tendo Achilles, and knee contractures. He had lower limb
weakness, particularly hip ﬂexion and knee extension. Deep
tendon reﬂexes were reduced at the knee and absent at the
ankle. There were no abnormal sensory signs and the
examination of the upper limb extremities was normal.
Laboratory test showed normal serum total creatine kinase.
Nerve conduction studies showed normal sensory and motor
amplitudes and conduction velocities, and electromyography
(EMG) revealed chronic neurogenic changes. Magnetic reso-
nance imaging of the thighs demonstrated severe focal muscle
atrophy affecting both quadriceps musculature, especially
vastus lateralis, vastus intermedius and rectus femoris. To a
lesser extent, hip adductor muscles were also affected.
Hamstring compartments were relatively preserved and there
was no sign of active inﬂammation. (Fig. 1B).
The probands father (II 3) and brother (III 1) also had similar
phenotype. Both had congenital hip dislocations and talipes
equinovarus. They also had prominent proximal muscle
wasting in the lower extremities (Fig. 1C). The EMG of II3
showed chronic neurogenic changes in upper limbs as well aslower limbs. The clinical features of these subjects and other
family members are summarised in the Table 1.
The pedigree was suggestive of an autosomal dominant
disorder (Fig. 1A). The proband was tested with a panel of 56
genes associated with inherited peripheral neuropathies,
using Agilent SureSelectXT2 custom target enrichment system
and Next Generation Sequencing, and found to harbour a
heterogeneous missense variant in exon 8 of the DYNC1H1
gene, c.1809 A > T, p.Glu603Asp (NM_001376.4). Screening of
other family members conﬁrmed segregation in affected
individuals. p.Glu603, located in the tail domain of the protein,
is highly conserved across species (Fig. 1D). Recently a different
mutation, p.Glu603Val (NM_001376.4) in the same location has
also been reported to cause SMALED [7].
3. Discussion
We identiﬁed a family with SMALED caused by a missense
mutation in DYNC1H1. The main clinical features were
congenital hip displacement, talipes, delayed motor develop-
ment, wasting and weakness in lower limbs with relative
sparing of upper extremities and very slow disease progres-
sion. Others have reported similar SMALED phenotype
associated with DYNC1H1 mutations [2,3,7–14]. Symptoms
tend to manifest at birth or infancy, and typically by the ﬁrst
decade of life. The severity of the symptoms may vary. A
mother with a pathogenic DYNC1H1 mutation only had
difﬁculty with squatting and quadriceps wasting, which was
revealed by a muscle computed tomography scan, whereas her
two sons had typical SMALED phenotype [8]. Quadriceps is the
commonest muscle group that is affected, but distal lower
limb muscles can also be affected. Although the upper
extremities are often spared, there are some reports of upper
limb wasting and weakness. Scapular winging is one of the
common upper limb features. The EMG of the upper limb
muscles also showed neurogenic changes in one of our cases
(II 3). Besides wasting and weakness, arthrogryposes in the
lower limb is another common feature, particularly congenital
hip dislocation and talipes equinovarus. Spine deformity,
especially lumber hyperlordosis is also prevalent. Therefore, it
is not surprising that gait development is delayed and
eventually most of them learn to walk unaided, but often
have a waddling gait. Rarely, they may also have intellectual
disability and epilepsy [12,15]. MRI brain is scarcely performed
in SMALED to assess cortical abnormalities.
Lower limb predilection in DYNC1H1 mutation associated
SMA is thought to reﬂect a localised pattern of anterior horn
cell loss. The static or very slowly progressive clinical course
together with congenital arthrogryposes suggest that the
clinically signiﬁcant loss of anterior horn cells occurs
prenatally and is largely completed by birth. SMALED caused
by DYNC1H1 mutations is not a fatal condition and the lack of
autopsy examination makes it difﬁcult to prove these
hypotheses.
There are other phenotypes that have been associated with
DYNC1H1 mutations. Weedon et al. reported DYNC1H1 muta-
tions in a large family with Charcot Marie Tooth type 2 [16].
Early onset, delayed motor development, distal lower limb
wasting and weakness and pes cavus deformity were the core
Fig. 1 – (A) Pedigree structure; I 1 and I 2 died before they could be tested for mutations. II 1 and II 2 refused genetic testing. (B)
The muscle MRI of the proband showed severe quadriceps wasting. (C) Severe lower limb wasting in the proband's father. (D)
Amino acid sequence of the mutation site is conserved across many species.
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tent with Charcot Marie Tooth. Upper limb involvement was
less frequent. Also, intact ﬁne touch, vibration sensation and
proprioception, frequent proximal lower limb muscle involve-
ment, spinal deformity, hip problems and a broad-based
waddling gait were some of the atypical features that were
present in many members of the family. In addition, few had
delay in speech development and intellectual disability [16].Therefore, after revaluating the phenotype reported in the
original paper, we suggest that this phenotype resembles
SMALED, an early onset static or slow progressive motor
neuropathy rather than Charcot Marie Tooth.
Hereditary mental retardation with cortical neural
migration defects is another phenotype that has been
associated with DYNC1H1 mutations [15,17,18]. Besides
variable degrees of cognitive impairment, they have severe
Table 1 – Clinical features of all affected family members.
Patient Age (Y) Phenotype
I 2 82 She had lower limb muscle
wasting and weakness. She
walked with a waddling gait.
II 1 60 He had lower limb muscle wasting
and weakness. He also had
learning difﬁculties and epilepsy.
II 2 59 He had bilateral talipes
equinovarus, congenital hip
dislocation and scoliosis. He had
lower limb weakness and
difﬁculties with walking.
II 3 58 He had bilateral talipes
equinovarus and congenital hip
dislocation requiring surgeries. He
also had bilateral pes cavus,
wasting of muscles (particularly
quadriceps), reduced reﬂexes, but
normal sensation in the lower
limbs and walked very slowly
with a waddling gait.
III 1 32 He had similar features as II 3.
III 2 30 He had similar features as II 3.
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ract and dimorphism have also been reported in this
phenotype [19,20]. A proportion may have arthrogryposes
and limb weakness or deformity [15,17,18]. They often have
global developmental delay. Histopathological examination
of two foetal brains with DYNC1H1 mutations revealed fronto-
parietal polymicrogyria, corpus callosum and cortico-spinal
tracts dysgenesis, brainstem and cerebellar abnormalities as
well as severe disruption of cortical lamination. Immunohis-
tochemical studies showed cell proliferation defects and
migration failure of the postmitotic neuroblast towards the
cortical plate [21]. There is no clear genotype-phenotype
correlations observed, but SMALED causing mutations more
commonly occur around the tail domain whereas hereditary
mental retardation with cortical neural migration phenotype
causing mutations are more frequent around the motor
domain [7].
4. Conclusions
Mutations in DYNC1H1 have two main phenotypes: early onset
static or slow progressive motor neuropathy with lower limb
predilection and hereditary mental retardation with cortical
neural migration defects. Some individuals may have over-
lapping features of both phenotypes. There are only handful
families with SMALED described in the literature. We report a
pedigree with a DYNC1H1 mutation. Further studies are
required to appreciate the full extent of clinical presentations
as well as the natural history of disorders associated with
mutations in DYNC1H1.
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